TickerKhojComparison · NSE · data 2026-11-01
Dr. Agarwal's Health Care Ltd. vs Dr. Lal PathLabs Limited
In plain words
Size: Dr. Lal PathLabs Limited is about 2 times the market value of Dr. Agarwal's Health Care Ltd..
Valuation (P/E): Dr. Agarwal's Health Care Ltd. 109.5 vs Dr. Lal PathLabs Limited 58.9.
Return on equity: Dr. Lal PathLabs Limited 21.6% vs Dr. Agarwal's Health Care Ltd. 6.8%.
Profit growth over 3 years: Dr. Lal PathLabs Limited 28.3% a year vs Dr. Agarwal's Health Care Ltd. 12.3% a year.
Debt to equity: Dr. Agarwal's Health Care Ltd. 0.53 vs Dr. Lal PathLabs Limited 0.08.
Differences in the numbers, not a recommendation of either stock.
Side by side
| AGARWALEYE | LALPATHLAB | |
|---|---|---|
| Price | ₹509.2 | ₹1,906.4 |
| Market cap | ₹16,116 cr | ₹31,997 cr |
| P/E | 109.5 | 58.9 |
| P/B | — | — |
| ROE | 6.8% | 21.6% |
| ROCE | 9.1% | 25.3% |
| Debt / equity | 0.53 | 0.08 |
| Operating margin | 14.5% | 23.0% |
| Dividend yield | 0.00% | 0.84% |
| Sales growth, 3 years (yearly) | 26.9% | 11.1% |
| Profit growth, 3 years (yearly) | 12.3% | 28.3% |
| 1-year return | -1.4% | 23.7% |
| Revenue, last 12 months | ₹2,207 cr | ₹2,891 cr |
| Net profit, last 12 months | ₹148 cr | ₹542 cr |
| Latest quarter | Jun 2026 | Jun 2026 |
| Quarter net profit | ₹45 cr | ₹170 cr |
| Quarter profit vs a year earlier | +50.5% | +28.0% |
| Promoter holding | 32.33% | 52.93% |
| Health check | Average (4.9/10) | Strong (8/10) |
Common questions
Which has a higher P/E, Dr. Agarwal's Health Care Ltd. or Dr. Lal PathLabs Limited?
Dr. Agarwal's Health Care Ltd. trades at the higher P/E (109.5 against 58.9). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Dr. Lal PathLabs Limited (21.6% against 6.8%).
Which carries more debt?
Dr. Agarwal's Health Care Ltd. has the higher debt-to-equity ratio (0.53 against 0.08).